Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (688336) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Why is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. ?

With a growth in Net Profit of 121.14%, the company declared Very Positive results in Jun 26

The company has declared positive results for the last 15 consecutive quarters
OPERATING CASH FLOW(Y) Highest at CNY 3,036.37 MM
ROCE(HY) Highest at 43.38%
NET PROFIT(Q) At CNY 167.93 MM has Grown at 127.03%

With ROE of 33.75%, it has a fair valuation with a 4.31 Price to Book Value

Over the past year, while the stock has generated a return of 17.53%, its profits have risen by 333.4% ; the PEG ratio of the company is 0
At the current price, the company has a high dividend yield of 0.6

Market Beating performance in long term as well as near term

Along with generating 17.53% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

16.32%

1.25

74.03%

China Shanghai Composite

3.23%

0.23

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

41.68%

EBIT Growth (5y)

74.60%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

0.28

Tax Ratio

13.10%

Dividend Payout Ratio

7.09%

Pledged Shares

Institutional Holding

ROCE (avg)

11.45%

ROE (avg)

3.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.31

EV to EBIT

11.13

EV to EBITDA

10.82

EV to Capital Employed

4.99

EV to Sales

8.26

PEG Ratio

0.04

Dividend Yield

0.55%

ROCE (Latest)

44.87%

ROE (Latest)

33.75%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 3,036.37 MM

ROCE(HY)

Highest at 43.38%

NET PROFIT(Q)

At CNY 167.93 MM has Grown at 127.03%

RAW MATERIAL COST(Y)

Fallen by -23.12% (YoY

CASH AND EQV(HY)

Highest at CNY 6,739.93 MM

DIVIDEND PER SHARE(HY)

Highest at CNY 21.44

NET SALES(Q)

At CNY 434.47 MM has Grown at 31.3%

PRE-TAX PROFIT(Q)

At CNY 123.1 MM has Grown at 90.47%

-1What is not working for the Company

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.49 times

Here's what is working for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Operating Cash Flow

Highest at CNY 3,036.37 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

At CNY 167.93 MM has Grown at 127.03%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

At CNY 434.47 MM has Grown at 31.3%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 123.1 MM has Grown at 90.47%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Cash and Eqv

Highest at CNY 6,739.93 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Dividend per share

Highest at CNY 21.44

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (CNY)

Raw Material Cost

Fallen by -23.12% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Inventory Turnover Ratio

Lowest at 1.49 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio